CD40LG and neoplasm: We next wanted to test the abscopal effects of MSC-CD3-CD40L treatment using a metastatic tumor model in which tumors were implanted on both the left and right flanks of mice, but only the primary tumor was treated with MSC-CD3-CD40L.